ONWARD Announces Appointment of Vivian Riefberg to Board of Directors
Retrieved on:
Monday, September 26, 2022
Biotechnology, Health, Surgery, Medical Devices, Dutch public broadcasting system, Movement, McKinsey & Company, PBS, Nature, Public, Harvard Business School, Industry, Business, Davos, Government, Technology, University of Virginia Darden School of Business, Leadership, ARC, NIH, Child, U.S. FDA, Spinal cord injury, PHA, Financial compensation, Company, Obesity, Intellectual property, History, High Tech Campus Eindhoven, Science, Partnership, Spinal cord, First Lady Michelle Obama (painting), Radcliffe College, Forward-looking statement, Board of directors, Board, Health, American, Publication, Johns Hopkins School of Medicine, Quality of life, Solution, Uncertainty, Darden, World Economic Forum, Multimedia, University, Euronext, Management, Pharmaceutical industry, Medical device
ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced the appointment of Vivian Riefberg as a non-executive member of its Board of Directors.
Key Points:
- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced the appointment of Vivian Riefberg as a non-executive member of its Board of Directors.
- Her appointment to the Board will be presented for shareholder approval at the next Annual General Meeting.
- View the full release here: https://www.businesswire.com/news/home/20220926005494/en/
Vivian Riefberg joins the ONWARD Medical Board of Directors (Photo: Business Wire)
Vivian Riefberg is a distinguished expert in health care, government, and strategy. - ONWARD has the opportunity to build a very special enterprise that is both successful and impactful, said Vivian Riefberg.